These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 9823320

  • 1. Estrogen receptor expression activates the transcriptional and growth-inhibitory response to retinoids without enhanced retinoic acid receptor alpha expression.
    Rosenauer A, Nervi C, Davison K, Lamph WW, Mader S, Miller WH.
    Cancer Res; 1998 Nov 15; 58(22):5110-6. PubMed ID: 9823320
    [Abstract] [Full Text] [Related]

  • 2. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein.
    Rubin M, Fenig E, Rosenauer A, Menendez-Botet C, Achkar C, Bentel JM, Yahalom J, Mendelsohn J, Miller WH.
    Cancer Res; 1994 Dec 15; 54(24):6549-56. PubMed ID: 7987855
    [Abstract] [Full Text] [Related]

  • 3. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RAR alpha gene expression and sensitivity to growth inhibition by retinoic acid.
    Sheikh MS, Shao ZM, Chen JC, Hussain A, Jetten AM, Fontana JA.
    J Cell Biochem; 1993 Dec 15; 53(4):394-404. PubMed ID: 8300756
    [Abstract] [Full Text] [Related]

  • 4. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI, Chao WR, Pine P, Jong L, Hobbs PD, Rudd CK, Quick TC, Niles RM, Zhang XK, Lombardo A.
    Cancer Res; 1995 Oct 01; 55(19):4446-51. PubMed ID: 7671258
    [Abstract] [Full Text] [Related]

  • 5. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH.
    Mol Cancer Res; 2004 Sep 01; 2(9):523-31. PubMed ID: 15383631
    [Abstract] [Full Text] [Related]

  • 6. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L, Gudas LJ.
    J Cell Physiol; 2002 Nov 01; 193(2):244-52. PubMed ID: 12385002
    [Abstract] [Full Text] [Related]

  • 7. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells.
    Zhao Z, Zhang ZP, Soprano DR, Soprano KJ.
    Exp Cell Res; 1995 Aug 01; 219(2):555-61. PubMed ID: 7641808
    [Abstract] [Full Text] [Related]

  • 8. Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells.
    Agadir A, Shealy YF, Hill DL, Zhang X.
    Cancer Res; 1997 Aug 15; 57(16):3444-50. PubMed ID: 9270011
    [Abstract] [Full Text] [Related]

  • 9. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P, Teng M, Chandraratna RA, Heyman RA, Allegretto EA.
    Cancer Res; 1997 Jul 01; 57(13):2642-50. PubMed ID: 9205071
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid increases tyrosine phosphorylation of focal adhesion kinase and paxillin in MCF-7 human breast cancer cells.
    Zhu WY, Jones CS, Amin S, Matsukuma K, Haque M, Vuligonda V, Chandraratna RA, De Luca LM.
    Cancer Res; 1999 Jan 01; 59(1):85-90. PubMed ID: 9892191
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis induction in cancer cells by a novel analogue of 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid lacking retinoid receptor transcriptional activation activity.
    Dawson MI, Hobbs PD, Peterson VJ, Leid M, Lange CW, Feng KC, Chen Gq, Gu J, Li H, Kolluri SK, Zhang Xk, Zhang Y, Fontana JA.
    Cancer Res; 2001 Jun 15; 61(12):4723-30. PubMed ID: 11406543
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H, Dawson MI, Hong WK, Lotan R.
    Oncogene; 1997 Oct 23; 15(17):2109-18. PubMed ID: 9366527
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 14. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis.
    Afonja O, Juste D, Das S, Matsuhashi S, Samuels HH.
    Oncogene; 2004 Oct 21; 23(49):8135-45. PubMed ID: 15361828
    [Abstract] [Full Text] [Related]

  • 15. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells.
    Chen Y, Dokmanovic M, Stein WD, Ardecky RJ, Roninson IB.
    Cancer Res; 2006 Sep 01; 66(17):8749-61. PubMed ID: 16951191
    [Abstract] [Full Text] [Related]

  • 16. Thyroid hormone enhancement of estradiol stimulation of breast carcinoma proliferation.
    Shao ZM, Sheikh MS, Rishi AK, Dawson MI, Li XS, Wilber JF, Feng P, Fontana JA.
    Exp Cell Res; 1995 May 01; 218(1):1-8. PubMed ID: 7737350
    [Abstract] [Full Text] [Related]

  • 17. Farnesol, a mevalonate pathway intermediate, stimulates MCF-7 breast cancer cell growth through farnesoid-X-receptor-mediated estrogen receptor activation.
    Journe F, Laurent G, Chaboteaux C, Nonclercq D, Durbecq V, Larsimont D, Body JJ.
    Breast Cancer Res Treat; 2008 Jan 01; 107(1):49-61. PubMed ID: 17333335
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of cytokeratins 8 and 18 in human breast cancer T47D cells is retinoid-specific and retinoic acid receptor-dependent.
    Jing Y, Zhang J, Waxman S, Mira-y-Lopez R.
    Differentiation; 1996 May 01; 60(2):109-17. PubMed ID: 8641545
    [Abstract] [Full Text] [Related]

  • 19. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X, Jhaveri P, Hussain-Hakimjee EA, Mehta RG.
    Carcinogenesis; 2007 May 01; 28(5):1000-7. PubMed ID: 17130524
    [Abstract] [Full Text] [Related]

  • 20. Human breast cancer cells and normal mammary epithelial cells: retinol metabolism and growth inhibition by the retinol metabolite 4-oxoretinol.
    Chen AC, Guo X, Derguini F, Gudas LJ.
    Cancer Res; 1997 Oct 15; 57(20):4642-51. PubMed ID: 9377581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.